Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor-Reference-Cited by-同舟云学术

Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor

Published:2018-11-13 Issue:3 Volume:48 Page:185-197
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Pedersen SJ¹²,Weber U³,Said-Nahal R⁴,Sørensen IJ¹²⁵,Loft AG⁶⁷,Kollerup G¹,Juul L¹,Frandsen PB¹,Thamsborg G¹,Madsen OR¹,Møller J⁸,Balding L⁸,Jurik AG⁹¹⁰,Østergaard M¹²³

Affiliation:

1. Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark

2. COPECARE, Copenhagen Center for Arthritis Research, Rigshospitalet, Copenhagen, Denmark

3. Department of Rheumatology, King Christian X Hospital, Gråsten and University of Southern Denmark, Odense, Denmark

4. Department of Rheumatology, Versailles Saint Quentin University, Ambroise-Paré Hospital, Paris, France

5. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

6. Department of Rheumatology, Hospital Lillebælt, Vejle, Denmark

7. Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark

8. Department of Radiology, Herlev Hospital, Copenhagen, Denmark

9. Department of Radiology, Aarhus University Hospital, Aarhus, Denmark

10. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2018.1506822

Reference52 articles.

1. Ankylosing spondylitis

2. Spondyloarthritis

3. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis

4. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis

5. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies;Expert Review of Clinical Immunology;2024-07-29

2. Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study;Arthritis & Rheumatology;2024-04-30

3. Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis—results from two randomized controlled trials;Arthritis Research & Therapy;2023-08-25

4. Syndesmophyte Growth in Ankylosing Spondylitis: from Laboratory to Bedside;Current Rheumatology Reports;2023-05-01

5. Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint?;RMD Open;2022-12